During the weekly Global TeleRounds on Wednesday, April 8, experts from the Department of Neurosurgery at Mount Sinai presented perspectives on COVID-19 from New York City.

Joshua B. Bederson, MD, provided an inside look at Mount Sinai’s response to COVID-19, including the redeployment of neurosurgeons to the ICU. He outlined the hierarchy and workflow as adopted by Mount Sinai from the Society of Critical Care Medicine to meet the increased demands on the health system. Since the disease causes thrombosis in many instances, the expertise of the neurological team is often required to treat stroke, hemorrhage, or other cerebrovascular events.

Sharam Majidi, MD, provided a deeper look at the neurological manifestations of COVID-19, such as stroke, encephalopathy, ataxia, and seizure. Dr. Majidi discussed the biology, neuroinvasive propensity, and increased thrombotic risk of the virus, as well as treatment strategies.